Abstract
This article shows the publications that we consider the most relevant on congenital heart disease in the last year. The COVID-19 pandemic has continued to mark scientific activity in this period. There has been concerns about the risk of complications from COVID-19 among adults with congenital heart disease (CHD). Likewise, the involvement of children with CHD has been studied. This year, the European guidelines for the treatment of CHD have been published, the second edition after 10years, that will be very useful in the treatment of these complex patients. Among the original publications, we highlight the contributions related to risk stratification in the primary prevention of ventricular arrhythmias, Fontan and liver disease, and the progress in percutaneous pulmonary valve implant techniques, the application of new drugs for advanced heart failure in complex CHD and in systemic right ventricle and long-term complications of young adults with transposition of the great arteries undergoing arterial switch surgery.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
